CDK4-IN-5
CDK4-IN-5 is a potent, orally active and selective CDK4 inhibitor. CDK4-IN-5 suppresses CDK4 expression and downregulates the CDK4/CyclinD1 complex. CDK4-IN-5 induces G0/G1 phase cell cycle arrest in bladder cancer cells via CyclinD1 expression suppression. CDK4-IN-5 selectively exerts activity against bladder cancer cells. CDK4-IN-5 can be used for the research of bladder cancer.
For research use only. We do not sell to patients.
- Formula: C28H40O6
- Molecular Weight:472.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
Cdk4/cyclin D1 |
CDK4-IN-5 (compound 2a) (0.016-50 μM; 72 h) potently inhibits the viability of T24 and 5637 bladder cancer cells with IC50 values of 0.44 μM and 0.49 μM, respectively, while demonstrating favorable selectivity over normal SV-HUC-1 cells (IC50 = 4.51 μM)[1].
CDK4-IN-5 (0.1 μM; 24-72 h) exerts a time-dependent inhibitory effect on the proliferation of T24 and 5637 bladder cancer cells[1].
CDK4-IN-5 (150-300 nM; 10-14 days) potently and durably suppresses colony formation of T24 and 5637 bladder cancer cells in a dose-dependent manner[1].
CDK4-IN-5 (600-1200 nM; 24 h) induces dose-dependent G0/G1 phase cell cycle arrest in T24 and 5637 bladder cancer cells[1].
CDK4-IN-5 (120-3000 nM; 48 h) dose-dependently downregulates CDK4 and CyclinD1 protein expression in T24 bladder cancer cells[1].
CDK4-IN-5 stably binds to the ATP-binding pocket of CDK4, with a most favorable binding energy of -10.1 kcal/mol at the CDK4 site[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T24, 5637 cells
-
Concentration:150; 300 nM
-
Incubation Time:10-14 days
-
Result:Inhibited colony formation of T24 and 5637 cells in a dose-dependent manner.
Showed a marked inhibitory effect in both T24 and 5637 cells.
-
Cell Line:T24, 5637 cells
-
Concentration:0.1 μM
-
Incubation Time:24 h, 48 h, 72 h
-
Result:Showed no significant inhibition at 24 h.
Decreased OD values by 37.41% in T24 cells and 50.90% in 5637 cells by 48 h.
Reduced OD values further to 45.47% in T24 cells and 51.89% in 5637 cells by 72 h.
-
Cell Line:T24, 5637 cells
-
Concentration:600; 1200 nM
-
Incubation Time:24 h
-
Result:Induced accumulation of cells in the G0/G1 phase with concurrent reduction in S phase population.
Increased G0/G1 phase percentage from 57.16% to 81.22% in T24 cells and from 44.10% to 63.55% in 5637 cells at 600 nM.
Further increased G0/G1 phase percentage to 83.12% in T24 cells and 66.74% in 5637 cells at 1200 nM, with S phase fractions decreasing to 9.17% in T24 cells and 26.99% in 5637 cells.
-
Cell Line:human bladder cancer T24 cells
-
Concentration:120; 600; 3000 nM
-
Incubation Time:48 h
-
Result:Significantly reduced CDK4 expression in a dose-dependent manner.
Decreased CyclinD1 levels in a dose-dependent manner.
Chemical Information
-
Molecular Weight 472.61
-
Formula C28H40O6
-
SMILES
C[C@@]1(CCC([C@@H](CCC2[C@H]3C)C)[C@]42OO1)O[C@H]4O[C@H]3OC(C(C)C5=CC=C(C=C5)CC(C)C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz